ANNA ENNIS-MARTINEZ: Open Payments
NPI 1720322209 · STRASBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,884 in 99 payments from 18 companies in 2025. Trend: 2023 $1,255 · 2024 $1,652 · 2025 $1,884
Food & beverage: $1,884
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $676 |
| Novo Nordisk Inc | 15 | $306 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $154 |
| Astellas Pharma US Inc | 5 | $113 |
| Lilly USA, LLC | 5 | $104 |
| AstraZeneca Pharmaceuticals LP | 5 | $102 |
| Axsome Therapeutics, Inc. | 4 | $90 |
| PFIZER INC. | 4 | $78 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $48 |
| Phathom Pharmaceuticals, Inc. | 1 | $35 |
Products named: UBRELVY, VRAYLAR, CAPLYTA, QULIPTA, Veozah, Ozempic, Auvelity, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
